This study comprehensively analyzes the federal and Georgia state Research and Development (R&D) tax credit frameworks applicable to businesses in Marietta, Georgia. Through five detailed industry case studies, it examines how local economic history intersects with Internal Revenue Code (IRC) § 41, O.C.G.A. § 48-7-40.12, and recent administrative guidance to drive technological innovation.

Case Study 1: Aerospace and Defense Manufacturing

The aerospace and defense sector represents the foundational pillar of Marietta’s modern industrial economy. The development of this specific industry in Marietta was catalyzed by geographic and geopolitical necessities during the mid-twentieth century. Following the Japanese attack on Pearl Harbor, the United States War Department sought to decentralize defense manufacturing away from vulnerable coastlines. Marietta, strategically located near the Western and Atlantic Railroad and situated inland, was selected in 1942 for the construction of Air Force Plant No. 6. Operated initially by the Bell Aircraft Corporation, this 4.2 million-square-foot facility, colloquially known as the “Bell Bomber” plant, produced 663 B-29 Superfortresses and employed over 28,000 workers by 1945. Following a brief post-war closure, the Lockheed Corporation (now Lockheed Martin) assumed control of the facility in 1951 to refurbish aircraft for the Korean War, establishing a permanent presence that would ultimately produce the C-130 Hercules, the C-141 Starlifter, the C-5 Galaxy, and subcomponents for fifth-generation fighters like the F-22 Raptor and F-35 Lightning II.

This continuous, multi-generational presence of advanced aerospace manufacturing cultivated a localized workforce with specialized skills in precision engineering, aerodynamics, and composite materials, drawing a vast network of tier-one and tier-two suppliers to the Marietta region.

R&D Tax Credit Eligibility and Case Law Application

For aerospace contractors in Marietta, eligibility for the federal R&D tax credit under IRC § 41 hinges on successfully navigating the four-part test, particularly the “Process of Experimentation” and the “Funded Research” exclusion. Aerospace engineering inherently satisfies the “Technological in Nature” requirement, as it relies on the hard sciences of physics and aerodynamics. However, the documentation of experimentation is rigorously scrutinized. According to the IRS Audit Techniques Guide for the Aerospace Industry, taxpayers must demonstrate that substantially all (at least 80%) of the claimed activities were evaluative and designed to resolve technological uncertainties regarding the capability, method, or appropriate design of the business component.

The most critical legal precedent for this sector originates directly from Marietta. In Lockheed Martin Corp. v. United States, 210 F.3d 1366 (Fed. Cir. 2000), the federal government challenged the aerospace manufacturer’s claim for research credits on the grounds that the research was performed under fixed-price government contracts and was therefore “funded”. Under IRC § 41(d)(4)(H), funded research is ineligible for the credit. The court established a two-prong standard: research is funded if payment is not contingent on the success of the research, or if the taxpayer does not retain “substantial rights” to the results. The appellate court ruled in favor of the taxpayer, determining that because the defense contractor retained the right to use the research results in its own business without paying the government for that privilege, it maintained substantial rights. This landmark decision secures the eligibility of Marietta’s aerospace supply chain to claim QREs for government contract work, provided the contractual language does not explicitly divest the manufacturer of intellectual property rights.

Under Georgia state law, aerospace operations satisfy the definition of a “business enterprise” engaged in manufacturing and research and development. To claim the Georgia credit, all wages paid and supplies purchased must be physically sourced to research conducted within the state. For Lockheed Martin and its localized supply chain, the concentration of assembly and testing facilities in Marietta ensures that localized engineering wages and prototype supplies directly increase the state base amount calculation, yielding a 10% credit on excess QREs.

Case Study 2: Biotechnology and Life Sciences

The biotechnology and life sciences industry in Marietta developed through a convergence of strategic real estate redevelopment, access to a highly educated talent pool, and a supportive regional economic ecosystem. Historically, the broader Atlanta metropolitan statistical area functioned as the epicenter for healthcare due to the presence of the Centers for Disease Control and Prevention (CDC) and major research universities. Marietta successfully captured a highly specialized segment of this market—specifically medical device manufacturing and tissue regeneration—by leveraging its industrial infrastructure. The city’s proactive zoning and the redevelopment of areas like the Franklin Gateway corridor provided biotech firms with affordable, scalable laboratory and clean-room spaces.

A prime example is the MiMedx Group, founded in 2008, which established its corporate headquarters and primary research facility in Marietta. The company specializes in processing human placental tissue to develop advanced wound care and surgical allografts, utilizing its proprietary PURION® process. Similarly, MiRus, a medical device company developing novel molybdenum-rhenium (MoRe®) alloys for orthopedic and spinal implants, expanded its footprint into a 70,000-square-foot facility in Marietta. The presence of Kennesaw State University (KSU) provides a continuous pipeline of engineering and biological science graduates, functioning as an external R&D engine that lowers workforce acquisition costs and reduces structural risk for these emerging firms.

R&D Tax Credit Eligibility and Case Law Application

For biotechnology companies in Marietta, qualifying research activities frequently involve pre-clinical studies, the design of aseptic processing methodologies, and the engineering of delivery mechanisms for regenerative tissues. Under the federal four-part test, these activities face intense IRS scrutiny regarding the exact point at which product development ends and commercial production begins. IRC § 41(d)(4)(A) strictly excludes any research conducted after the beginning of commercial production. The IRS Audit Techniques Guide for the Pharmaceutical and Biotechnology Industries requires examiners to differentiate between clinical trials necessary to overcome biological uncertainties (which qualify as QREs) and post-approval Phase IV testing utilized for marketing or routine quality control (which are excluded).

Furthermore, the “Shrink-Back Rule” is heavily utilized in medical device R&D. If the overall business component (e.g., a complete surgical implant system) does not meet the requirement that 80% of activities constitute a process of experimentation, the taxpayer must apply the test to the next most significant sub-component. Marietta-based medical device manufacturers must contemporaneously document the specific iterative testing performed on novel alloys or specific mechanical joints within their devices to withstand IRS examinations.

At the state level, Georgia offers a crucial administrative mechanism for pre-revenue biotechnology firms. Enacted under O.C.G.A. § 48-7-40.12, the Georgia R&D tax credit permits businesses to apply the credit against up to 50% of their state income tax liability. Because companies like MiMedx or MiRus may operate for years with heavy R&D expenditures but no taxable income, the state allows excess credits to offset state payroll withholding liabilities. Recent statutory updates effective for the 2025 tax year drastically improved this benefit by expanding the election window. Previously, businesses were required to file Form IT-WH (Notice of Intent) within 30 days of filing their Georgia return. Under the revised administrative guidance, biotechnology taxpayers in Marietta now have up to three years from the original return due date to make or amend this withholding election. This procedural flexibility allows life science startups to retroactively monetize clinical trial wages, preserving vital operational cash flow.

Case Study 3: Advanced Manufacturing and Automation

The evolution of advanced manufacturing in Marietta is a direct downstream effect of the aerospace industry’s demand for high-tolerance, precision-machined components. As the local workforce gained proficiency in complex mechanical engineering following the establishment of the Bell Bomber plant, the city attracted a diverse array of manufacturers specializing in robotics, customized equipment, and smart infrastructure. Marietta’s strategic location along Interstate 75 and proximity to the Hartsfield-Jackson Atlanta International Airport provides a logistical advantage, enabling the rapid deployment of manufactured goods.

Firms such as Plethora, a leader in the on-demand manufacturing of custom prototypes, and Flock Safety, an automated drone and security camera manufacturer, have established significant production facilities in the Marietta and greater Cobb County area. These entities rely on the Georgia Quick Start program and the Advanced Manufacturing Center at local technical colleges to continuously upskill their labor force in computer numerical control (CNC) programming and programmable logic controllers (PLCs).

R&D Tax Credit Eligibility and Case Law Application

The federal R&D tax credit requires advanced manufacturers to distinguish between routine fabrication and qualified engineering. Merely building a product to a customer’s requested specifications does not qualify for the credit if the process utilizes established engineering parameters without testing technological hypotheses. Under the IRC § 174 test, an activity must seek to discover information that eliminates uncertainty concerning the capability, method, or appropriate design of the product.

This distinction was heavily litigated in Phoenix Design Group, Inc. v. Commissioner (T.C. Memo). The Tax Court evaluated a firm employing professional engineers to design complex mechanical systems. The taxpayer argued that its sophisticated engineering calculations eliminated design uncertainty, thus qualifying the activities under Section 174. The court rejected this argument, ruling that the application of standard, albeit complex, engineering principles without an investigatory activity or an evaluative process of trial and error fails the Section 174 test and the Process of Experimentation test.

Furthermore, the recent Seventh Circuit decision in Little Sandy Coal Co., Inc. v. Comm’r (62 F.4th 287, 2023) established a rigid precedent for manufacturing firms. The court denied R&D credits to a manufacturer because the taxpayer failed to prove that “substantially all” (80% or more) of the activities involved in designing the product constituted elements of a process of experimentation. To comply with these legal precedents, advanced manufacturers in Marietta cannot rely on broad estimations of engineering time. They must maintain granular, contemporaneous documentation detailing the specific alternatives evaluated—such as testing different metallurgical compositions to prevent thermal warping during CNC machining—and track the exact hours dedicated to evaluating those alternatives.

Under Georgia’s O.C.G.A. § 48-7-40.12, the definition of a “business enterprise” explicitly includes manufacturing operations but strictly excludes retail businesses. If a Marietta-based manufacturer sells its prototype drones or smart infrastructure directly to end consumers, it must carefully structure its operations. The statute dictates that an entity otherwise meeting the definition of a business enterprise will not be disqualified due to the retail activities of an affiliate entity, provided the manufacturing and retail operations are properly segmented for gross receipts calculations.

Case Study 4: Software Development and Information Technology

Marietta’s emergence as a formidable hub for software development and Information Technology (IT) is heavily tied to the academic expansion of Kennesaw State University (KSU). In 1948, the Southern Technical Institute was established as an extension of Georgia Tech to educate World War II veterans. This institution eventually became Southern Polytechnic State University before merging with KSU, establishing the KSU Marietta Campus. The College of Computing and Software Engineering located on this campus provides an institutional anchor, generating specialized talent in computer game design, artificial intelligence, and cybersecurity.

As Atlanta solidified its reputation as “Transaction Alley”—processing over 70% of all U.S. electronic payment transactions—the demand for software engineering outpaced the urban core’s infrastructure. Marietta absorbed this overflow, attracting tech startups and established IT departments seeking suburban accessibility combined with high-density technological infrastructure. Software firms in Marietta develop proprietary cloud architecture, complex financial modeling algorithms, and secure integration protocols for legacy enterprise systems.

R&D Tax Credit Eligibility and Case Law Application

Software development is subject to a bifurcated regulatory environment under federal law. If software is developed to be sold, leased, or licensed to third parties, it is evaluated under the standard four-part test of IRC § 41. However, software developed primarily for the taxpayer’s own internal use (Internal Use Software, or IUS) must satisfy an additional three-part “High Threshold of Innovation” (HTI) test. The HTI test requires that the software be highly innovative (resulting in a substantial reduction in cost or improvement in speed), involve significant economic risk, and not be commercially available for use without substantial modification. IT firms in Marietta developing proprietary internal enterprise resource planning (ERP) systems or custom data analytics platforms must meet this elevated evidentiary burden.

A massive paradigm shift for the software industry occurred with the passage of the One Big Beautiful Bill Act (OBBBA) in 2025. Previously, under the Tax Cuts and Jobs Act of 2017, all software development costs were explicitly categorized as Section 174 specified research or experimental (SRE) expenditures and were subject to mandatory five-year amortization. The OBBBA enacted IRC § 174A, which restored the immediate deduction of domestic R&E expenditures for tax years beginning after December 31, 2024, and permanently affirmed that domestic software development costs qualify for this immediate expensing. Marietta IT firms can now immediately deduct the wages of their software engineers, vastly improving corporate cash flow. Furthermore, small software businesses (under $31 million in gross receipts) can utilize Revenue Procedure 2025-28 to retroactively apply the Section 174A expensing rules to tax years 2022 through 2024 by filing amended returns.

At the state level, telecommunications and data processing operations are statutorily eligible for the Georgia R&D tax credit. The primary administrative challenge for Marietta software firms under O.C.G.A. § 48-7-40.12 involves the calculation of the “base amount.” The base amount is tied to the taxpayer’s “Georgia gross receipts,” defined as the numerator of the gross receipts factor under O.C.G.A. § 48-7-31. For Software-as-a-Service (SaaS) providers, sourcing intangible revenue specifically to Georgia users requires sophisticated apportionment methodologies. If a firm fails to accurately partition its Georgia-sourced revenue from its national revenue, the base amount calculation will be artificially inflated, directly reducing the available 10% credit on excess QREs.

Case Study 5: Specialty Chemicals and Materials

The specialty chemicals and materials industry in Marietta originated from the agrarian demands of the nineteenth and early twentieth centuries. Georgia’s heavy reliance on cotton and agriculture necessitated robust chemical fertilizer production, leading to the establishment of numerous industrial chemical plants across the state. As agricultural dominance waned, these chemical facilities pivoted toward specialty materials, leveraging Marietta’s established rail infrastructure and reliable water utility systems.

Today, the sector is characterized by global entities operating high-capacity production and research facilities. For example, Kemira, a Finnish global leader in water-intensive chemistry, operates a major manufacturing and research site in Marietta that recently celebrated a milestone of 25 years without a lost-time accident. The Dow Chemical Company also maintains a footprint in the region, focusing on advanced materials science and customized chemical formulations.

R&D Tax Credit Eligibility and Case Law Application

R&D in the specialty chemicals sector involves synthesizing new polymer formulations, creating environmentally sustainable solvents, and scaling up chemical reactions from small bench-top laboratory environments to full commercial production reactors. Under the federal four-part test, these activities face stringent review regarding the classification of supply expenses.

Under IRC § 41(b)(2)(C), QREs include amounts paid for “supplies” used in the conduct of qualified research, explicitly excluding land, land improvements, and depreciable property. The legal boundary for chemical supply QREs was defined in Union Carbide Corp. v. Comm’r (T.C. Memo. 2009-50, aff’d 697 F.3d 181, 2d Cir. 2012). In this case, the chemical manufacturer attempted to claim the massive costs of raw materials used during commercial production runs, arguing that because the production runs were being monitored to test a new process, the raw materials constituted R&D supplies. The Tax Court disallowed these costs, ruling that the supplies were used primarily to manufacture products for sale, not for a process of experimentation. Therefore, chemical manufacturers in Marietta must strictly isolate the raw materials consumed in laboratory or pilot-scale tests from those used in commercial production runs. If a pilot run produces a chemical compound that is subsequently sold, the IRS will likely challenge the inclusion of those supply costs as QREs.

Under Georgia state law, chemical producers clearly fall under the manufacturing provision of O.C.G.A. § 48-7-40.12. Because chemical manufacturing is highly capital-intensive, firms in Marietta often generate massive R&D tax credits that exceed the 50% state income tax liability cap. Historically, these excess credits were carried forward for 10 years. However, the Georgia legislature’s passage of House Bill 1181 drastically altered this long-term tax planning strategy. For credits generated in taxable years beginning on or after January 1, 2025, the carryforward period has been permanently reduced to five years. This creates a dual-track accounting mandate: specialty chemical firms must meticulously track pre-2025 credits (which retain the 10-year lifespan) separate from post-2025 credits to ensure older credits are exhausted before they expire, fundamentally altering corporate financial forecasting.

Detailed Analysis of Federal Tax Administration Guidance

The federal tax administration landscape for R&D expenditures is currently undergoing a period of profound procedural evolution. The intersection of IRC § 41 (the credit mechanism) and IRC § 174 (the deduction mechanism) dictates the financial architecture of corporate innovation.

The Impact of the One Big Beautiful Bill Act (OBBBA)

Prior to 2022, taxpayers could immediately expense their domestic R&D costs under Section 174 while simultaneously claiming the R&D credit under Section 41. The Tax Cuts and Jobs Act (TCJA) of 2017 removed this immediate expensing option, forcing taxpayers to capitalize and amortize domestic R&E costs over five years, severely restricting cash flow.

The One Big Beautiful Bill Act (OBBBA), signed into law in 2025, reversed this restrictive policy. The OBBBA created IRC § 174A, which permanently restored the ability for taxpayers to fully expense domestic R&E expenditures incurred in tax years beginning after December 31, 2024. Importantly, foreign R&E expenditures remain subject to the TCJA’s 15-year capitalization and amortization requirement, preserving the legislative intent to onshore innovation.

The IRS issued Revenue Procedure 2025-28 to govern the transition. For businesses with unamortized domestic R&E expenditures from the 2022–2024 tax years, the guidance provides catch-up mechanisms. Taxpayers may elect to deduct the entire remaining unamortized balance in 2025, or they may elect a split deduction, amortizing the remainder evenly across 2025 and 2026. Furthermore, eligible small businesses (defined under Section 448(c) as having average annual gross receipts of $31 million or less) possess the unique ability to apply Section 174A retroactively. By filing amended returns for 2022 through 2024, these small entities can retroactively expense their R&D costs, potentially unlocking massive tax refunds. However, the legislation also modified Section 280C(c), stipulating that taxpayers who take the immediate deduction under Section 174A must reduce that deduction by the amount of the research credit claimed under Section 41, or alternatively elect a reduced credit to avoid adding the excess back to taxable income.

Heightened Documentation Standards: Form 6765 Section G

Concurrent with the restoration of immediate expensing, the IRS has escalated its evidentiary requirements for claiming the Section 41 credit. The IRS has introduced Section G to Form 6765 (Credit for Increasing Research Activities), which fundamentally alters how QREs are reported.

Historically, taxpayers could report aggregate wage, supply, and contract totals across their entire R&D operation. Under the new rules, which become mandatory for tax years beginning after 2025, taxpayers must segment their QREs by specific “business components”. Taxpayers must report up to 50 business components that comprise at least 80% of their total QREs. For each component, the taxpayer must provide a qualitative description of the technological uncertainty faced, the specific alternatives evaluated during the process of experimentation, and designate the salaries broken down by direct research, direct supervision, and direct support.

This reporting requirement codifies recent case law (such as the Little Sandy Coal decision) demanding component-level proof of experimentation. While certain qualified small businesses and taxpayers with total QREs under $1.5 million are exempt from Section G, the vast majority of medium and large enterprises in Marietta must now deploy specialized time-tracking and project management software to contemporaneously document their adherence to the four-part test.

Detailed Analysis of Georgia State Tax Administration Guidance

The Georgia Department of Revenue (DOR) administers the state R&D tax credit through a highly structured compliance regimen designed to ensure that state-funded incentives directly correspond to localized economic activity. The credit is non-refundable and functions as an incremental incentive, rewarding companies that increase their research spending year over year.

Base Amount Calculation and Income Tax Offsets

Under O.C.G.A. § 48-7-40.12, the credit equals 10% of the excess of the current year’s Georgia QREs over the established base amount. The base amount is determined by calculating the average ratio of the entity’s aggregate QREs to its Georgia gross receipts for the preceding three taxable years. This average ratio is then multiplied by the current year’s Georgia gross receipts. Statutorily, the base amount cannot exceed 30% of the current year’s gross receipts (the 0.300 rule).

Once calculated, the credit application is capped at 50% of the business enterprise’s remaining Georgia net income tax liability for the year. Georgia DOR regulations explicitly mandate an “order of credits,” requiring the R&D credit to be applied after all other available state income tax credits (such as the Manufacturer’s Investment Tax Credit or the Jobs Tax Credit). Because it is applied last, and capped at 50%, healthy businesses frequently generate surplus credits that cannot be immediately absorbed by their income tax liability.

Procedural Mechanics of the Payroll Withholding Offset

To prevent the stranding of capital, especially for start-ups that do not yet generate taxable income, Georgia allows excess R&D credits to be redirected to offset state payroll withholding tax liabilities. This is a powerful mechanism for generating immediate cash flow, but it requires strict adherence to DOR filing protocols.

To execute the offset, the taxpayer must first file their state corporate income tax return with Form IT-RD attached, demonstrating the calculation of the credit and the application of the 50% income tax limitation. Subsequently, the taxpayer must file Form IT-WH (Notice of Intent) electronically through the Georgia Tax Center.

In a significant pro-business regulatory update effective for the 2025 tax year, the DOR expanded the deadline for filing Form IT-WH. Previously constrained to a 30-day window post-return filing, taxpayers now have a three-year statutory window from the original return due date to make or amend the withholding election. The DOR maintains a 120-day review period following the submission of Form IT-WH. If approved, the DOR issues a Letter of Eligibility specifying the exact dollar amount that can be applied against future payroll withholding. The state explicitly notes that this offset functions prospectively; the DOR will not issue refunds for past withholding payments already remitted. Consequently, businesses must accurately forecast their payroll tax liabilities to maximize the utility of the approved offset.

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 400 West Peachtree Street NW, Atlanta, Georgia is less than 20 miles away from Marietta and provides R&D tax credit consulting and advisory services to Marietta and the surrounding areas such as: Atlanta, South Fulton, Sandy Springs, Roswell and Johns Creek.

If you have any questions or need further assistance, please call or email our local Georgia Partner on (404) 448-1354.
Feel free to book a quick teleconference with one of our Georgia R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.